Tag

Study Flaws

All articles tagged with #study flaws

Flawed Abstract Sparks Produce-Lung Cancer Claim, Critics Say
health1 month ago

Flawed Abstract Sparks Produce-Lung Cancer Claim, Critics Say

A conference abstract from USC researchers suggests that higher intake of fruits, vegetables, and whole grains among younger non-smokers with lung cancer may be linked to the disease, but experts say the study is too flawed to support any causal claim—no control group, arbitrary groupings, and speculative pesticide explanations—while previous research generally shows produce reduces cancer risk.

Biostatistician Debunks Flawed Study Linking Vaccines to Chronic Illness
health8 months ago

Biostatistician Debunks Flawed Study Linking Vaccines to Chronic Illness

A flawed study claiming vaccines cause chronic illnesses in children is critically analyzed, revealing significant biases such as surveillance bias, detection bias, and confounding factors, which undermine its conclusions. The study's design issues, including unequal follow-up times and differences in healthcare utilization, prevent it from establishing a causal link between vaccines and long-term health risks.

Flawed Study by RFK Jr. Ally Links Vaccines to Chronic Illness
health8 months ago

Flawed Study by RFK Jr. Ally Links Vaccines to Chronic Illness

A flawed, unpublished study claiming vaccines increase chronic illnesses is criticized for fundamental methodological errors, particularly detection bias, and is contrasted with robust peer-reviewed research showing no such link. The article emphasizes the importance of proper scientific standards in informing public health policy and warns against political misuse of flawed data.

FDA Evaluates MDMA for PTSD Amid Safety Concerns and Study Issues
health2 years ago

FDA Evaluates MDMA for PTSD Amid Safety Concerns and Study Issues

The FDA has raised concerns about the health risks and study flaws in the use of MDMA, commonly known as Ecstasy, for treating PTSD. The agency's analysis highlighted issues such as bias in the studies and significant increases in blood pressure and pulse rates, which could lead to cardiovascular events. An independent advisory panel will review the application by Lykos Therapeutics for MDMA-assisted therapy next week. Approval of this treatment would represent a major shift in the regulation of psychedelic compounds.